Results 171 to 180 of about 12,119 (223)

Comparison of treatment efficacy and cost-effectiveness of rituximab and oral agents among patients with neuromyelitis optica spectrum disorders: a population-based cohort study. [PDF]

Ther Adv Neurol Disord
Lee HL, Kang M, Seok JM, Kim BJ, Kim BJ.
europepmc   +1 more source

Association Between Serum Interleukin-32 Level and Disease Status in Cases with Neuromyelitis Optica Spectrum Disorders. [PDF]

J Inflamm Res
Yu HF, Xu J, Fang Y, Xiao LC.
europepmc   +1 more source

Clinical characteristics of anti-myelin oligodendrocyte glycoprotein antibody among aquaporin-4 negative neuromyelitis optica spectrum disorders in Egyptian patients. [PDF]

Sci Rep
Taha SI, Bakr SI, Fouad NT, Zamzam D, Mohamed YA.   +4 more
europepmc   +1 more source

Integrated omics profiling reveals systemic dysregulation and potential biomarkers in the blood of patients with neuromyelitis optica spectrum disorders. [PDF]

J Transl Med
Xie Z, Zhou Q, Hu J, He L, Meng H, Liu X, Sun G, Luo Z, Feng Y, Li L, Chu X, Du C, Yang D, Yang X, Zhang J, Ge C, Zhang X, Chen S, Geng M.   +18 more
europepmc   +1 more source

First-in-Human Study of BAT4406F, an ADCC-Enhanced Fully Humanized Anti-CD20 Monoclonal Antibody in Patients With Neuromyelitis Optica Spectrum Disorders. [PDF]

CNS Neurosci Ther
Yu H, Chen Y, Qi Y, Yang H, Cao G, Yang W, Li S, Yang X, Wang H, Zhang J, Chen X.   +10 more
europepmc   +1 more source

4-Octyl itaconate inhibits inflammation via the NLRP3 pathway in neuromyelitis optica spectrum disorders. [PDF]

Ann Clin Transl Neurol
Li T, Li JW, Qin YH, Liu R, Xu XN, Li X, Li LM, Feng B, Yang L, Yang CS.   +9 more
europepmc   +1 more source

Worse recovery from acute attacks and faster disability accumulation highlights the unmet need for improved treatment in patients with late-onset neuromyelitis optica spectrum disorders (COPTER-LO study). [PDF]

Front Immunol
Kretschmer JR, Tkachenko D, Kümpfel T, Havla J, Engels D, Paul F, Schindler P, Bellmann-Strobl J, Berthele A, Giglhuber K, Zappe C, Klotz L, Revie L, Dawin E, Senel M, Tumani H, Bergh FT, Warnke C, Kraemer M, Walter A, Bayas A, Zettl UK, Lauenstein AS, Yalachkov Y, Etgen T, Kaste M, Luessi F, Gingele S, Passoke S, Weber MS, Sieb JP, Haarmann A, Oschmann P, Rothhammer V, Geis C, Kowarik MC, Kern P, Grothe M, Stephanik H, Angstwurm K, Hoffmann F, Wallwitz U, Wildemann B, Jarius S, Stellmann JP, Pakeerathan T, Schwake C, Ayzenberg I, Kleiter I, Fischer K, Aktas O, Ringelstein M, Häußler V, Trebst C, Hümmert MW.   +54 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Neuromyelitis Optica Spectrum Disorder

New England Journal of Medicine, 2022
Dean M. Wingerchuk, Claudia F. Lucchinetti   +1 more
openaire   +4 more sources